MedTrace Logo

Intrabone Infusion of Umbilical Cord Blood Stem Cells

NCT01711788 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2017-10-05

No results posted yet for this study

Summary

The purpose of this study is to determine if the method of intrabone infusion of hematologic stem cells can increase and accelerate hematopoietic reconstitution after umbilical cord blood transplantation in pediatric patients.

Conditions

  • Hematopoietic Stem Cell Transplantation

Interventions

PROCEDURE

Intrabone infusion of umbilical cord blood stem cells

Sponsors & Collaborators

  • Michel Duval, MD

    collaborator UNKNOWN

  • Pierre Teira, MD

    collaborator UNKNOWN

  • Sonia Cellot, MD, PhD

    collaborator UNKNOWN

  • Isabelle Louis, PhD

    collaborator UNKNOWN

  • Elie Haddad, MD, PhD

    collaborator UNKNOWN

  • Marie-France Vachon, MScN

    collaborator UNKNOWN

  • Marion Cortier, PhD

    collaborator UNKNOWN

  • Henrique Bittencourt, MD, PhD

    lead OTHER

Principal Investigators

  • Henrique Bittencourt, MD, PhD · St. Justine's Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2017-10-03
Completion
2017-10-03

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01711788 on ClinicalTrials.gov